Human Genome Sciences, SmithKline Beecham Inc. deal

HGSI received a $25 million payment from SmithKline, representing the third and final milestone under its collaboration with the pharma company. The payment was triggered by HGSI delivering a specified number of partial gene sequences during 1995 at a specified minimum quarterly rate. ...